NOVOLIN-L: INSULIN HUMAN ZINC SUSPENSION.
The INSULIN HUMAN ZINC SUSPENSION is a the manufacturer industrial component. Key specifications include special_features: RECOMBINANT DNA ORIGIN (YEAST), primary_container_type: VIAL, MULTIPLE DOSE, therapeutic_equivalent: NOVOLIN BY NOVO NORDISK, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 10.000 MILLILITERS, active_medicament_medicinal_strength: 100.000 USP UNITS INSULIN PER MILLILITER. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-190-3582, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | RECOMBINANT DNA ORIGIN (YEAST) |
| primary_container_type | VIAL, MULTIPLE DOSE |
| therapeutic_equivalent | NOVOLIN BY NOVO NORDISK |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 10.000 MILLILITERS |
| active_medicament_medicinal_strength | 100.000 USP UNITS INSULIN PER MILLILITER |
| part_name_assigned_by_controlling_agency | INSULIN HUMAN ZINC SUSPENSION USP 100UN/ML 10ML MULTI DOSE VIAL |
| NSN | 6505-01-190-3582 |
| THERAPEUTIC EQUIVALENT | NOVOLIN BY NOVO NORDISK |
| PRIMARY CONTAINER CONTENT QUANTITY | 10.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL, MULTIPLE DOSE |
| SPECIAL FEATURES | RECOMBINANT DNA ORIGIN (YEAST) |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | INSULIN HUMAN ZINC SUSPENSION USP 100UN/ML 10ML MULTI DOSE VIAL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 100.000 USP UNITS INSULIN PER MILLILITER |